343 related articles for article (PubMed ID: 20802484)
1. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma.
Lajoie S; Lewkowich IP; Suzuki Y; Clark JR; Sproles AA; Dienger K; Budelsky AL; Wills-Karp M
Nat Immunol; 2010 Oct; 11(10):928-35. PubMed ID: 20802484
[TBL] [Abstract][Full Text] [Related]
2. Distinct roles of the anaphylatoxins C3a and C5a in dendritic cell-mediated allergic asthma.
Engelke C; Wiese AV; Schmudde I; Ender F; Ströver HA; Vollbrandt T; König P; Laumonnier Y; Köhl J
J Immunol; 2014 Dec; 193(11):5387-401. PubMed ID: 25355927
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation.
Baelder R; Fuchs B; Bautsch W; Zwirner J; Köhl J; Hoymann HG; Glaab T; Erpenbeck V; Krug N; Braun A
J Immunol; 2005 Jan; 174(2):783-9. PubMed ID: 15634899
[TBL] [Abstract][Full Text] [Related]
4. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.
Schäfer B; Piliponsky AM; Oka T; Song CH; Gerard NP; Gerard C; Tsai M; Kalesnikoff J; Galli SJ
J Allergy Clin Immunol; 2013 Feb; 131(2):541-8.e1-9. PubMed ID: 22728083
[TBL] [Abstract][Full Text] [Related]
5. Complement factor C5 inhibition reduces type 2 responses without affecting group 2 innate lymphoid cells in a house dust mite induced murine asthma model.
Yang J; Ramirez Moral I; van 't Veer C; de Vos AF; de Beer R; Roelofs JJTH; Morgan BP; van der Poll T
Respir Res; 2019 Jul; 20(1):165. PubMed ID: 31340811
[TBL] [Abstract][Full Text] [Related]
6. Evidence for anti-inflammatory effects of C5a on the innate IL-17A/IL-23 axis.
Bosmann M; Sarma JV; Atefi G; Zetoune FS; Ward PA
FASEB J; 2012 Apr; 26(4):1640-51. PubMed ID: 22202675
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production.
Liu J; Lin F; Strainic MG; An F; Miller RH; Altuntas CZ; Heeger PS; Tuohy VK; Medof ME
J Immunol; 2008 May; 180(9):5882-9. PubMed ID: 18424707
[TBL] [Abstract][Full Text] [Related]
8. A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma.
Köhl J; Baelder R; Lewkowich IP; Pandey MK; Hawlisch H; Wang L; Best J; Herman NS; Sproles AA; Zwirner J; Whitsett JA; Gerard C; Sfyroera G; Lambris JD; Wills-Karp M
J Clin Invest; 2006 Mar; 116(3):783-96. PubMed ID: 16511606
[TBL] [Abstract][Full Text] [Related]
9. Allergen uptake, activation, and IL-23 production by pulmonary myeloid DCs drives airway hyperresponsiveness in asthma-susceptible mice.
Lewkowich IP; Lajoie S; Clark JR; Herman NS; Sproles AA; Wills-Karp M
PLoS One; 2008; 3(12):e3879. PubMed ID: 19060952
[TBL] [Abstract][Full Text] [Related]
10. Regulation and function of anaphylatoxins and their receptors in allergic asthma.
Laumonnier Y; Wiese AV; Figge J; Karsten C
Mol Immunol; 2017 Apr; 84():51-56. PubMed ID: 27916272
[TBL] [Abstract][Full Text] [Related]
11. Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy.
Drouin SM; Corry DB; Hollman TJ; Kildsgaard J; Wetsel RA
J Immunol; 2002 Nov; 169(10):5926-33. PubMed ID: 12421977
[TBL] [Abstract][Full Text] [Related]
12. A protective role for C5a in the development of allergic asthma associated with altered levels of B7-H1 and B7-DC on plasmacytoid dendritic cells.
Zhang X; Lewkowich IP; Köhl G; Clark JR; Wills-Karp M; Köhl J
J Immunol; 2009 Apr; 182(8):5123-30. PubMed ID: 19342693
[TBL] [Abstract][Full Text] [Related]
13. Respiratory Syncytial Virus Exacerbates OVA-mediated asthma in mice through C5a-C5aR regulating CD4
Hu X; Li X; Hu C; Qin L; He R; Luo L; Tang W; Feng J
Sci Rep; 2017 Nov; 7(1):15207. PubMed ID: 29123203
[TBL] [Abstract][Full Text] [Related]
14. A critical role for C5L2 in the pathogenesis of experimental allergic asthma.
Zhang X; Schmudde I; Laumonnier Y; Pandey MK; Clark JR; König P; Gerard NP; Gerard C; Wills-Karp M; Köhl J
J Immunol; 2010 Dec; 185(11):6741-52. PubMed ID: 20974988
[TBL] [Abstract][Full Text] [Related]
15. Deletion of the complement C5a receptor alleviates the severity of acute pneumococcal otitis media following influenza A virus infection in mice.
Tong HH; Lambert G; Li YX; Thurman JM; Stahl GL; Douthitt K; Clancy C; He Y; Bowman AS
PLoS One; 2014; 9(4):e95160. PubMed ID: 24740152
[TBL] [Abstract][Full Text] [Related]
16. Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a.
Ali H
Immunol Lett; 2010 Jan; 128(1):36-45. PubMed ID: 19895849
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
Laumonnier Y; Karsten CM; Köhl G; Köhl J
Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
[TBL] [Abstract][Full Text] [Related]
18. Long-term sublingual immunotherapy for Japanese cedar pollinosis and the levels of IL-17A and complement components 3a and 5a.
Sakashita M; Yamada T; Imoto Y; Hirota T; Tamari M; Ito Y; Kubo S; Osawa Y; Takahashi N; Fujieda S
Cytokine; 2015 Sep; 75(1):181-5. PubMed ID: 25934649
[TBL] [Abstract][Full Text] [Related]
19. IL-17A promotes the exacerbation of IL-33-induced airway hyperresponsiveness by enhancing neutrophilic inflammation via CXCR2 signaling in mice.
Mizutani N; Nabe T; Yoshino S
J Immunol; 2014 Feb; 192(4):1372-84. PubMed ID: 24446518
[TBL] [Abstract][Full Text] [Related]
20. IL-17A enhances IL-13 activity by enhancing IL-13-induced signal transducer and activator of transcription 6 activation.
Hall SL; Baker T; Lajoie S; Richgels PK; Yang Y; McAlees JW; van Lier A; Wills-Karp M; Sivaprasad U; Acciani TH; LeCras TD; Myers JB; Kovacic MB; Lewkowich IP
J Allergy Clin Immunol; 2017 Feb; 139(2):462-471.e14. PubMed ID: 27417023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
